TENX - TENAX THERAPEUTICS, INC.

5.83
0.080   1.372%

Share volume: 3,990
Last Updated: 04-08-2025
Pharmaceutical Products/Pharmaceutical Preparations: 0.05%

PREVIOUS CLOSE
CHG
CHG%
$5.75
0.08
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
12%
Profitability 8%
Dept financing 4%
Liquidity 50%
Performance 10%
Company vs Stock growth
vs
N/A
4.750 6.260
1.510 31.79%
+ Add row to compare
Performance
5 Days
0.52%
1 Month
-3.16%
3 Months
-6.57%
6 Months
72.49%
1 Year
48.72%
2 Year
-80.51%
Key data
Stock price
$5.83
P/E Ratio 
N/A
DAY RANGE
$5.75 - $6.17
EPS 
-$5.56
52 WEEK RANGE
$2.77 - $7.89
52 WEEK CHANGE
$50.65
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
1.770 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
0.48
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$22,839
AVERAGE 30 VOLUME 
$22,587
Company detail
CEO: Christopher T. Giordano
Region: US
Website: tenaxthera.com
Employees: 9
IPO year: 1997
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Tenax Therapeutics, Inc. engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. The company was founded in 1967 and is headquartered in Morrisville, North Carolina.

Recent news
loading